Ovid Therapeutics Inc (OVID)
3.15
-0.05
(-1.56%)
USD |
NASDAQ |
Apr 24, 16:00
3.175
+0.02
(+0.79%)
After-Hours: 20:00
Ovid Therapeutics Price: 3.15 for April 24, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 24, 2024 | 3.18 | 3.216 | 3.11 | 3.15 | 113121.0 |
Apr 23, 2024 | 3.16 | 3.244 | 3.11 | 3.20 | 110572.0 |
Apr 22, 2024 | 3.23 | 3.29 | 3.12 | 3.15 | 205940.0 |
Apr 19, 2024 | 3.19 | 3.29 | 3.17 | 3.23 | 176642.0 |
Apr 18, 2024 | 3.12 | 3.24 | 3.12 | 3.21 | 226932.0 |
Apr 17, 2024 | 3.18 | 3.22 | 3.05 | 3.11 | 160465.0 |
Apr 16, 2024 | 3.18 | 3.23 | 3.15 | 3.17 | 138008.0 |
Apr 15, 2024 | 3.21 | 3.24 | 3.198 | 3.20 | 131931.0 |
Apr 12, 2024 | 3.24 | 3.24 | 3.13 | 3.20 | 88254.00 |
Apr 11, 2024 | 3.19 | 3.29 | 3.173 | 3.27 | 76652.00 |
Apr 10, 2024 | 3.18 | 3.212 | 3.110 | 3.18 | 167577.0 |
Apr 09, 2024 | 3.22 | 3.322 | 3.20 | 3.24 | 136252.0 |
Apr 08, 2024 | 3.23 | 3.27 | 3.199 | 3.22 | 56495.00 |
Apr 05, 2024 | 3.14 | 3.35 | 3.06 | 3.25 | 186042.0 |
Apr 04, 2024 | 3.09 | 3.15 | 3.05 | 3.05 | 93251.00 |
Apr 03, 2024 | 3.05 | 3.09 | 3.03 | 3.05 | 89963.00 |
Apr 02, 2024 | 3.02 | 3.12 | 3.00 | 3.05 | 200077.0 |
Apr 01, 2024 | 3.08 | 3.17 | 3.05 | 3.09 | 151001.0 |
Mar 28, 2024 | 3.06 | 3.17 | 3.04 | 3.05 | 144551.0 |
Mar 27, 2024 | 3.05 | 3.12 | 3.00 | 3.05 | 169954.0 |
Mar 26, 2024 | 3.14 | 3.215 | 3.00 | 3.00 | 239299.0 |
Mar 25, 2024 | 3.20 | 3.27 | 3.04 | 3.09 | 170987.0 |
Mar 22, 2024 | 3.06 | 3.38 | 3.06 | 3.20 | 439476.0 |
Mar 21, 2024 | 2.99 | 3.22 | 2.95 | 3.05 | 440861.0 |
Mar 20, 2024 | 2.76 | 2.87 | 2.60 | 2.79 | 2.587M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.44
Minimum
Nov 07 2022
8.24
Maximum
Aug 19 2020
3.343
Average
3.29
Median
Feb 03 2021
Price Benchmarks
Ligand Pharmaceuticals Inc | 71.00 |
NovaBay Pharmaceuticals Inc | 0.0773 |
Palatin Technologies Inc | 1.73 |
iBio Inc | 1.90 |
Theriva Biologics Inc | 0.3686 |
Price Related Metrics
PS Ratio | 567.63 |
Price to Book Value | 2.537 |
Earnings Yield | -23.81% |
Market Cap | 222.74M |